tinkthank

Tilray to ALL TIME HIGH!

Long
tinkthank Updated   
NASDAQ:TLRY   Tilray Brands, Inc.
Im looking for a full legalization of marijuana in the whole western world by 2025.
America and Canada first.
Then Mexico and Europe will follow.

Tilray are the largest company in the sector with the most contacts and legal paperwork in place.
This company will be the largest stakeholder in the market and I believe a market cap of 100B USD isnt an exaggeration.

We're around 4B market cap today so that would take the company from ca 25 usd to 625 usd. = NEW ATH.
This is a long term investment where you should put part of your monthly salary in. Its a company in a growing sector (pun intended) and it will continiue to grow until at least 2030.

Marijuana has 99 more uses than 1(getting high) which will also drive this market to even higher market caps in the future.
Marijuana and hemp can for example be used as BIOFUEL, building material, clothing, and so on.
It has unlimited uses and is ENVORIMENTAL FRIENDLY. Weed will be the new gold in the future.
Trade active:
House voting on SAFE BANKING ACT today.

Which will allow Financial Institutions and Banks to do business with marijuana companies inside the US, Tilray included.
A first - very important step - towards a full legalisation.
Comment:
SAFE BANKING ACT (weed bill) HR1996 PASSED!
Very good first, and important, step for weed legalisation in the US!!
Comment:
God has sent me a message...
Yesterday a white bird knocked on my window.

Normally this symbolizes a positive change (economically).
Tilray is the only stock I own right now.

I see it as a message. Tilray will make me rich.
I recieved it yesterday. Today tilray is up 4%.
The start of a new era? New ATH will come, only question is when.
Comment:
yeye news every day coming out!
new deals, new shit.

- Times 100 most influentual companies list.
- Aphria merger complete.
- BANK OF AMERICA puts buy on tilray today 28/4.

Legalization in us 2022. Pretty much straight up from here
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.